News

Rovsing Completes Successful Share Issue and Debt Conversion

Rovsing Completes Successful Share Issue and Debt Conversion

Rovsing Completes Successful Share Issue and Debt Conversion

Rovsing A/S recently announced an important milestone in its financial journey with the completion of a directed share issue and debt conversion. This comes after their previous announcement, marking a significant step towards the company's growth strategy.

A Glimpse at the Share Issue Details

The company successfully subscribed for all 55,500 new shares. Out of this total, 44,660 shares were acquired through cash transactions at a price point of DKK 59.00 each, aligning with the market value determined by the board of directors. Additionally, 10,840 shares were part of a conversion tied to a convertible loan note issued earlier, at a subscription cost of DKK 36.90 per share.

Investor Participation

A select group of private investors participated in this share issue, including members from both the board of directors and management. The total funds raised reached an impressive DKK 3,034,976, which includes an important component coming from debt conversion amounting to DKK 399,996.

What This Means for Rovsing's Future

As a result of this successful capital increase, the new shares are expected to be registered with the Danish Business Authority, expanding the company’s total share capital to DKK 7,402,970. The new shares account for 8.10% of Rovsing’s capital prior to the increase, which will adjust to 7.50% post-issue.

Trading on Nasdaq Main Market

Investors can anticipate that these new shares will be listed and publicly traded on Nasdaq Main Market Copenhagen no later than a specified future date. This listing marks a critical opportunity for shareholders to gain from the company's ongoing and future development.

Understanding the Rights of New Shares

The newly issued shares will be freely transferable and will not possess any special rights. Shareholders will enjoy standard voting and dividend rights from the date the capital increase registers, solidifying Rovsing's commitment to transparency and shareholder value.

Total Shares After Capital Increase

Following the registration, the total number of shares will rise to 740,297 shares, each with a nominal value of DKK 10.00. This increase positions Rovsing for robust capital growth and aligns with its strategic vision.

CEO's Insights on the Capital Increase

Hjalti Pall Thorvardarson, the CEO of Rovsing, expressed confidence in this development, stating, “The successful completion of the Issue is a key enabler for Rovsing to execute on the updated strategy, supporting our efforts to perform the necessary due diligence and preparations of clear buy-and-build targets.” His words emphasize the excitement surrounding the plans for utilizing the new capital efficiently.

Appreciation for Investor Support

The board and management of Rovsing extended their gratitude to the investors and the lender involved in this directed share issue and debt conversion. A collaborative effort like this showcases the trust and enthusiasm the investor community has in the company’s vision and operations.

Contact Information

If you wish to learn more about Rovsing or engage with its management, you can reach out to:

Hjalti Pall Thorvardson, CEO
Tel: +45 53 39 18 88
Email: hpt@rovsing.dk

Sigurd Hundrup, CFO
Tel: +45 53 39 18 92
Email: shu@rovsing.dk

Frequently Asked Questions

What was the purpose of Rovsing's recent share issue?

The share issue was aimed at raising capital to support Rovsing’s updated strategic initiatives and enhance its operational capabilities.

How many shares were issued in the directed share issue?

A total of 55,500 new shares were subscribed and paid for in the directed share issue conducted by Rovsing.

What was the subscription price for the new shares?

The cash subscription price for the new shares was set at DKK 59.00, while shares obtained through debt conversion were priced at DKK 36.90.

When will the new shares start trading?

The new shares are expected to be listed and traded on Nasdaq Main Market Copenhagen by a specified date following the registration.

Who are the key individuals to contact for more information?

The primary contacts are Hjalti Pall Thorvardarson (CEO) and Sigurd Hundrup (CFO), who can provide insights into Rovsing’s operations and future strategy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GM Ditches NYSE for Nasdaq: What to Expect?

Updated Category News Views 159

The Big Migration: GM Moves to Nasdaq You know when an old dog changes its turf, it's looking for some new tricks. General Motors (NYSE: GM) has decided to pack its bags and leave the New York Stock Exchange (NYSE) for the Nasdaq Global Select Market. They’re sticking with the same ticker, "GM," but you can expect that big switcheroo come November 17, 2026. I can't be...

Continue Reading
Implantica's Strategic U.S. Entry with RefluxStop®

Updated Category News Views 102

Implantica's Ambitious Move into the U.S. Market Every now and then, a move in the medtech sector grabs everyone's attention, and that's what we got with Implantica's latest play. This company is pulling out the big guns to push its RefluxStop® device into the U.S. market—one of the toughest nuts to crack. They've roped in Dr. John C. Lipham, a leading U.S. surgeon, to...

Continue Reading
Gildan Faces Investor Class Action After Stock Tumbles

Updated Category News Views 15

Shake-Up at Gildan: Investors Take Legal Action Gildan Activewear Inc. (NYSE:GIL) got themselves in hot water, folks. They've landed on the wrong side of an investor class action lawsuit after claims of shady business tactics sent their stock plummeting like a rock in June. We're talking about an 18.75% nosedive here. That's not just a slip—it's a fall worth wearing a...

Continue Reading
Lektra Unveils EdgeStart: Green Earnings from AI

Updated Category News Views 31

AI and Solar Power: A New Revenue Stream Lektra's fresh off the blocks with EdgeStart, an AI server pushing building owners to make a buck off their idle solar power. These self-contained, 8-GPU NVIDIA cabinets don't just sit pretty; they’re money-makers, potentially turning an overlooked asset into a goldmine. If your building's solar panels are just loafing about...

Continue Reading
New Navy Contract Boosts X-Bow's Defense Portfolio

Updated Category News Views 77

Will X-Bow's CHAOS contract shake up defense? Ever get the feeling you're watching a scrappy upstart quietly transform an industry? That's the buzz around X-Bow Systems Inc (X-Bow®) as they announce a partnership with CoAspire for the U.S. Navy's CHAOS program. This ain't just another contract; it's a cornerstone moment for them. So, what's fueling the excitement?...

Continue Reading
Nakama's AniBiz Gains Power with New Investments

Updated Category News Views 12

Anime Titans Back AniBiz Think of the anime sector with a new sheriff in town, and its name is AniBiz.com. This platform, a brainchild of Nakama, Inc., just landed strategic investments from some heavyweight players in the anime world: TBS Group, Toei Animation, and TV TOKYO Holdings. The Significance of Strategic Support Ain’t no small potatoes here. We're talking the...

Continue Reading
KROMATID Joins CIRM's Genomic Analysis Initiative

Updated Category News Views 6

New Partnership Opens Doors for Genomic Mastery In a world where biotechnology races to meet the needs of modern medicine, KROMATID's recent nod as an Industry Resource Partnership (IRP) member, courtesy of the California Institute for Regenerative Medicine (CIRM), makes some noise worth noting. This membership isn't just a feather in their cap—it's their ticket to...

Continue Reading
Ultrasound Innovations: 2D, 3D, and 4D Explained

Updated Category News Views 24

Diving into the World of Ultrasound Imaging When you're in the trenches of expecting a new family member, the last thing you want is to get bogged down in technical jargon that doesn't make a lick of sense. Enter prenatal ultrasound imaging: 2D, 3D, and 4D. Each of these has a specific role in piecing together the puzzle of fetal development. Now, Erika Lambright, a...

Continue Reading
ASSA ABLOY Breaks Records in Q3 2026 Report

Updated Category News Views 35

Another Record Quarter for ASSA ABLOY Well, look who’s breaking records and not just fixing locks. ASSA ABLOY is strutting out of Q3 2026 with numbers worth a double take. The company, based in Stockholm, has reported record sales with a 7% bump, now standing at SEK 40,771 million. Organic growth accounts for a healthy 4%, and if you’re eyeballing where the muscle...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 31

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading

Top 5 Most Recently Viewed Articles

Transform Your Investment: What $1,000 Could Mean Today

Updated Category News Views 30

Transform Your Investment Journey with Booking Holdings Investing in the stock market can feel like a daunting task, yet some companies have proven to be extraordinarily rewarding over the years. One such company is Booking Holdings (NASDAQ: BKNG), which has delivered spectacular returns to its investors. Over the past two decades, its annualized return has outstripped...

Continue Reading
Mirantis Excels in Container Management: 2024 Gartner Recognition

Updated Category News Views 181

Mirantis Recognized as a Challenger by Gartner Mirantis recently announced with pride that it has been named a Challenger in the 2024 Gartner Magic Quadrant for Container Management. This esteemed recognition highlights Mirantis alongside prominent companies such as AWS, Google, and Microsoft. It reflects Mirantis' commitment to giving organizations exceptional control...

Continue Reading
SolarBank Secures $1.5 Million for Innovative EV Charger Projects

Updated Category News Views 172

The Big Picture: EV Charging Initiatives SolarBank has thrown its hat into the ring by applying for $1.5 million in grants for three fast EV charger projects. Now, these aren’t just any chargers; they’re positioned to be pivotal in SolarBank's evolving narrative as a frontrunner in the clean energy sector. The significance here? They’re not merely seeking...

Continue Reading
Nature's Way Unveils Exciting Sambucus Ultra Immune Chews

Updated Category News Views 151

Nature's Way Introduces Innovative Immune Support Chews Building on its award-winning Sambucus brand, Nature's Way presents a delightful new format that transforms immune support into a fun experience. The recently launched Sambucus Ultra Immune Juicy Burst is designed not just to support immune health but to do so in a tasty, enjoyable way that everyone can appreciate. A...

Continue Reading
Getinge's Hemopro 3 Boosts Endoscopic Vessel Harvesting

Updated Category News Views 8

Getinge's Latest Evolution in Endoscopic Vessel Harvesting Witnessing Getinge's launch of the Vasoview Hemopro 3 feels like catching the climax of a meticulous medical drama. This Swedish giant is pushing the envelope in coronary artery bypass grafting (CABG) procedures with this state-of-the-art Endoscopic Vessel Harvesting (EVH) System. For insiders in the healthcare...

Continue Reading